recommended by 

Notfalllabor

 

 

INNOVATION FOR LIFE

The early detection in such emergencies is one of the key factors and thus a decisive influence on the life-or-death of the affected people. With the development of our innovative diagnostic products, it is our goal to find better and more effective solutions for the early identification of essential health disorders such as heart attack or stroke. This is managed on a scientific basis and many years of intensive development work.

 

SEGMENTS AND PATIENTNUMBER

 

 

Gynkologie Bearbeitet2

10.000.000
PRE-ECLAMPSIA PATIENT 

DATA:
5-8 % PREGNANCIES ARE ACCOMPANIED BY PRE-ECLAMPSIA
(7 TIMES HIGHER IN THIRD WORLD COUNTRIES)
12.5 / 1,000 PREGNANCIES

WORLDWIDE 135 MIO. BIRTHSN

 

 

 

Neurologie Bearbeitet2
 
  

15.000.000
STROKE PATIENT

RISC FACTORS:
HIGH BLOOD PRESSURE
UNHEALTHY LIFESTYLE
OBESITY
GENETIC PREDISPOSITION  

 

 

 

Kardiologie Bearbeitet2
 

77.000.000
ACS / CHEST PAIN PATIENTS

RISC FACTORS:
HIGH BLOOD PRESSURE
UNHEALTHY LIFESTYLE
OBESITY (IS AROUND 27%)
GENETIC PREDISPOSITION

 

 

 


 

 

PRODUCTOVERVIEW

 

 

01653__j2

GYNECOLOGY

There is no established bio marker for preeclampsia.

This anables GPBB to be a new gold standard for the diagnosis of preeclampsia.


NEUROLOGY

There are no bio markers to delete a for stroke.

GPBB as the new gold standard for stroke.

This will lead to the input and improvements in stroke diagnosis guidelines.


CARDIOLOGY

GPBB is able to recognize AMI / ACS early after onset of chest pain [30min]. It is therefore faster than today's bio markers [4h]. This will establish GPBB as the new gold standard for the early diagnosis of ACS.